PG vs RNAC · P/E 25, rev $84.28B vs P/E 2.1, rev $38.9M
Procter & Gamble Company (PG) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
PG currently screens at market cap $373.53B and trailing P/E 25.3. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the PG and RNAC stock pages for the full models.
Not investment advice.